Furthermore, we mutated two key sites on METTL3 (D395A and W398A) 43 to make it inactive, and transfected CRC cells with WT-METTL3 with normal enzyme activity and MUT-METTL3 with loss of catalytic activity. This evidence concerns the gene METTL3 and colorectal carcinoma.